Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (9.836)

81

Anifrolumab : first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus

enthalten in: Expert review of clinical immunology | 2024

von Gensous, N. | Lazaro, E. | Blanco, P. | +1

82

Lecanemab : More Questions Than Answers!

enthalten in: Clinical drug investigation | 2024

von Kaur, U. | Reddy, J. | Tiwari, A. | +2

83

Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy : a case report and literature review

enthalten in: Frontiers in immunology | 2024

von He, L. | Li, H. | Wang, Y. | +11

84

Dupilumab Treatment in Pediatric Patients Aged 6-11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled : A Review

enthalten in: Drug design, development and therapy | 2024

von Cork, M. | Danby, S. | Rossi, A. | +1

85

Exploring DESTINY : the Past, Present, and Future of Trastuzumab Deruxtecan

enthalten in: Current oncology reports | 2024

von Ali, A. | Graff, S.

86

The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab : A Systematic Review and Meta-Analysis

enthalten in: Viruses | 2024

von Ko, P. | Kuo, M. | Kao, I. | +3

87

Biological Therapies for Pediatric Atopic Dermatitis - A Review

enthalten in: Current pediatric reviews | 2024

von Milano, G. | Forestieri, S. | Tedeschi, M. | +3

88

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab : A systematic review of the current knowledge towards an attempt to compare agents' efficacy

enthalten in: International forum of allergy & rhinology | 2024

von Papacharalampous, G. | Constantinidis, J. | Fotiadis, G. | +3

89

Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis - a meta-analysis of randomized clinical trials

enthalten in: Expert review of clinical immunology | 2024

von Marko, M. | Pawliczak, R.

CommentOn: Front Med (Lausanne). 2023 Apr 18;10:1165098. - PMID 37144036

90

Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis : Case series and literature review

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2024

von Kamide, Y. | Watai, K. | Nakamura, Y. | +4